Surgical Oncology And Breast Disease
Help Questions
USMLE Step 2 CK › Surgical Oncology And Breast Disease
A 46-year-old woman presents with a palpable breast mass. She has dense breasts on prior imaging and is worried that mammography will miss cancer. Exam shows a 2-cm firm mass; no skin changes. She has no contraindications to imaging. The clinician explains that for women ≥40 with a palpable mass, diagnostic mammography is first-line, often combined with targeted ultrasound; breast MRI is reserved for specific indications such as high-risk screening, problem-solving, or staging in selected cases, not as initial test for most palpable masses.
What is the most appropriate initial diagnostic test for this patient's breast mass?
Diagnostic mammography with targeted ultrasound of the palpable region
Repeat clinical breast exam after next menstrual cycle before imaging
Whole-body PET/CT to evaluate for occult primary and metastases
Therapeutic lumpectomy without imaging to avoid diagnostic delays
Breast MRI as the sole initial test due to dense breast tissue
Explanation
This question tests USMLE Step 2 CK skills in surgical oncology and breast disease management, focusing on evidence-based clinical decision-making. Understanding breast cancer management involves recognizing appropriate diagnostic and treatment strategies based on patient presentation and current guidelines. In this scenario, the patient's clinical findings and test results suggest a palpable mass in a woman with dense breasts requiring initial evaluation, which is key to determining the appropriate management step. The correct answer, choice A, is correct because it aligns with guidelines recommending diagnostic mammography with targeted ultrasound as first-line for palpable masses in women ≥40. Choice B is incorrect because it represents misuse of MRI as initial test, which often arises from overestimating its role in routine diagnostics. To effectively manage breast disease cases, students should stay updated on guidelines, understand risk stratification, and practice integrating clinical findings with management planning.
A 45-year-old G2P2 woman presents with a new right breast lump noticed 3 weeks ago. She reports mild tenderness but no fever, nipple discharge, or recent trauma. Menarche was at age 11; first pregnancy at 34. She drinks 1–2 glasses of wine nightly and has obesity. Her mother had breast cancer at 52. She has never had breast surgery and last screening mammogram was 4 years ago. On exam, there is a 2.5-cm firm, irregular, nonmobile mass in the upper outer quadrant of the right breast with subtle skin dimpling; no erythema. One right axillary node is palpable and firm. Vitals are normal. The clinician is concerned for malignancy and wants the most appropriate initial imaging as part of triple assessment (clinical exam, imaging, tissue diagnosis). According to current guidelines, evaluation of a palpable mass in a woman ≥40 begins with diagnostic mammography with targeted ultrasound as needed to further characterize the lesion and guide biopsy planning.
What is the most appropriate initial diagnostic test for this patient's breast mass?
PET/CT to evaluate for distant metastases before biopsy
Breast MRI with and without contrast for initial lesion characterization
Diagnostic mammography of both breasts with targeted right breast ultrasound
Empiric antibiotics and reassessment in 1 week for presumed mastitis
Repeat screening mammography in 6 months to assess interval change
Explanation
This question tests USMLE Step 2 CK skills in surgical oncology and breast disease management, focusing on evidence-based clinical decision-making. Understanding breast cancer management involves recognizing appropriate diagnostic and treatment strategies based on patient presentation and current guidelines. In this scenario, the patient's clinical findings and test results suggest a suspicious palpable mass with high malignancy risk due to family history and exam features, which is key to determining the appropriate management step. The correct answer, choice B, is correct because it aligns with guidelines recommending diagnostic mammography with targeted ultrasound for women ≥40 with palpable masses to characterize the lesion and guide biopsy. Choice A is incorrect because it represents an inappropriate initial imaging choice, which often arises from overreliance on advanced modalities without following stepwise evaluation protocols. To effectively manage breast disease cases, students should stay updated on guidelines, understand risk stratification, and practice integrating clinical findings with management planning.
A 62-year-old woman presents with a palpable right breast mass and recent unintentional 6-kg weight loss. She went through menopause at 50 and never used hormone therapy. She has hypertension and type 2 diabetes. Exam reveals a 3.5-cm hard, irregular mass with nipple retraction and peau d’orange overlying skin; two right axillary nodes are enlarged. Diagnostic mammography and ultrasound show a suspicious mass and abnormal nodes. Core biopsy confirms invasive ductal carcinoma, triple-negative. Staging CT shows no distant metastases. She asks whether breast-conserving surgery is possible. The surgeon explains that lumpectomy requires negative margins and is typically followed by whole-breast radiation; mastectomy is an alternative. Neoadjuvant chemotherapy is often recommended for stage II–III triple-negative disease to downstage tumor and assess response.
Which treatment option is most aligned with current clinical guidelines for this condition?
Immediate radical mastectomy with routine removal of pectoralis muscles
Neoadjuvant chemotherapy followed by surgery with appropriate axillary staging
Observation with imaging every 6 months because CT shows no metastases
Lumpectomy alone without radiation because margins can be negative
Tamoxifen therapy as primary treatment given high recurrence risk
Explanation
This question tests USMLE Step 2 CK skills in surgical oncology and breast disease management, focusing on evidence-based clinical decision-making. Understanding breast cancer management involves recognizing appropriate diagnostic and treatment strategies based on patient presentation and current guidelines. In this scenario, the patient's clinical findings and test results suggest locally advanced triple-negative breast cancer without metastases, which is key to determining the appropriate management step. The correct answer, choice B, is correct because it aligns with guidelines recommending neoadjuvant chemotherapy for stage II–III triple-negative disease to downstage the tumor and assess response before surgery. Choice A is incorrect because it represents undertreatment by omitting radiation, which often arises from misconceptions about margin status eliminating recurrence risk. To effectively manage breast disease cases, students should stay updated on guidelines, understand risk stratification, and practice integrating clinical findings with management planning.
A 55-year-old woman underwent lumpectomy and sentinel lymph node biopsy 3 weeks ago for a 1.6-cm invasive ductal carcinoma. Pathology shows clear margins, 0/2 sentinel nodes involved, ER/PR positive, HER2 negative, grade 2. She is recovering well and has no wound complications. She asks what follow-up and adjuvant care she needs to reduce recurrence risk. The surgeon reviews that breast-conserving therapy includes whole-breast radiation after lumpectomy, and ER-positive disease typically receives adjuvant endocrine therapy. Surveillance includes regular history/physical and annual mammography; routine PET/CT or tumor markers are not recommended in asymptomatic patients.
What is the most suitable follow-up plan post-surgery?
Prophylactic contralateral mastectomy as standard follow-up for all patients
Tumor marker monitoring monthly with CA 15-3 to detect recurrence
Annual mammography plus adjuvant whole-breast radiation and endocrine therapy
No radiation needed if margins are negative after lumpectomy
PET/CT every 6 months for 2 years to detect early metastasis
Explanation
This question tests USMLE Step 2 CK skills in surgical oncology and breast disease management, focusing on evidence-based clinical decision-making. Understanding breast cancer management involves recognizing appropriate diagnostic and treatment strategies based on patient presentation and current guidelines. In this scenario, the patient's clinical findings and test results suggest early-stage ER-positive breast cancer post-lumpectomy with negative nodes, which is key to determining the appropriate management step. The correct answer, choice A, is correct because it aligns with guidelines recommending annual mammography, whole-breast radiation, and endocrine therapy for surveillance and risk reduction. Choice B is incorrect because it represents overuse of advanced imaging, which often arises from anxiety-driven misconceptions about detecting asymptomatic metastases. To effectively manage breast disease cases, students should stay updated on guidelines, understand risk stratification, and practice integrating clinical findings with management planning.
A 38-year-old woman who is 24 weeks pregnant presents with a new left breast lump for 2 weeks. She denies fever or nipple discharge. She has no prior breast imaging. Exam shows a 2-cm firm mass without overlying erythema; no axillary nodes are palpable. She is concerned about fetal radiation exposure. The clinician explains that evaluation of a palpable mass in pregnancy begins with breast ultrasound, which is safe and can guide biopsy if suspicious; diagnostic mammography with abdominal shielding may be added if needed.
What is the most appropriate initial diagnostic test for this patient's breast mass?
Delay all imaging until after delivery unless severe pain develops
Targeted breast ultrasound of the palpable area
Breast MRI with gadolinium as the first-line pregnancy test
CT chest with contrast to evaluate for metastatic disease
Technetium bone scan to screen for skeletal metastases
Explanation
This question tests USMLE Step 2 CK skills in surgical oncology and breast disease management, focusing on evidence-based clinical decision-making. Understanding breast cancer management involves recognizing appropriate diagnostic and treatment strategies based on patient presentation and current guidelines. In this scenario, the patient's clinical findings and test results suggest a palpable mass during pregnancy requiring safe evaluation, which is key to determining the appropriate management step. The correct answer, choice A, is correct because it aligns with guidelines recommending targeted ultrasound as the initial test in pregnancy to avoid fetal radiation exposure. Choice C is incorrect because it represents inappropriate use of contrast agents, which often arises from ignoring pregnancy-specific safety concerns. To effectively manage breast disease cases, students should stay updated on guidelines, understand risk stratification, and practice integrating clinical findings with management planning.
A 66-year-old woman presents with progressive right breast skin thickening and redness for 3 weeks. She was treated with oral antibiotics for presumed mastitis without improvement. She denies breastfeeding and has no fever. Exam shows diffuse erythema involving more than one-third of the breast with peau d’orange and a poorly defined underlying firmness; ipsilateral axillary nodes are palpable. Diagnostic mammography and ultrasound show skin thickening and an ill-defined mass. Core biopsy confirms invasive carcinoma with dermal lymphatic invasion. The team discusses that inflammatory breast cancer is aggressive and typically managed with neoadjuvant systemic therapy followed by mastectomy and radiation, not upfront lumpectomy.
Which of the following is the most likely diagnosis given the patient's presentation and test results?
Fibroadenoma with reactive skin changes from hormonal cycling
Paget disease limited to the nipple-areolar complex without invasion
Acute bacterial mastitis requiring broader-spectrum antibiotics and drainage
Fat necrosis after trauma requiring reassurance only
Inflammatory breast cancer requiring neoadjuvant therapy and multimodal treatment
Explanation
This question tests USMLE Step 2 CK skills in surgical oncology and breast disease management, focusing on evidence-based clinical decision-making. Understanding breast cancer management involves recognizing appropriate diagnostic and treatment strategies based on patient presentation and current guidelines. In this scenario, the patient's clinical findings and test results suggest inflammatory breast cancer with failed antibiotic response and biopsy confirmation, which is key to determining the appropriate management step. The correct answer, choice A, is correct because it aligns with guidelines recommending neoadjuvant therapy followed by mastectomy and radiation for this aggressive subtype. Choice B is incorrect because it represents diagnostic delay, which often arises from misattributing symptoms to infection despite lack of improvement. To effectively manage breast disease cases, students should stay updated on guidelines, understand risk stratification, and practice integrating clinical findings with management planning.
A 52-year-old woman presents with unilateral eczematous changes of the left nipple for 4 months. She reports itching and occasional serous discharge. Topical steroids provided minimal relief. She has no fevers. Exam shows erythema and scaling of the nipple-areolar complex with slight crusting; a subtle subareolar firmness is appreciated. No axillary nodes are palpable. Diagnostic mammography shows microcalcifications beneath the nipple. Punch biopsy of the nipple shows malignant cells within the epidermis consistent with Paget disease. The clinician explains that this finding is usually associated with underlying DCIS or invasive carcinoma and requires breast imaging and definitive surgical management.
Which of the following is the most likely diagnosis given the patient's presentation and test results?
Inflammatory breast cancer without need for tissue diagnosis
Fibrocystic change requiring no imaging if symptoms are chronic
Paget disease of the breast associated with underlying ductal carcinoma
Duct ectasia managed with warm compresses and reassurance
Contact dermatitis requiring stronger topical corticosteroids only
Explanation
This question tests USMLE Step 2 CK skills in surgical oncology and breast disease management, focusing on evidence-based clinical decision-making. Understanding breast cancer management involves recognizing appropriate diagnostic and treatment strategies based on patient presentation and current guidelines. In this scenario, the patient's clinical findings and test results suggest Paget disease with underlying carcinoma confirmed by biopsy, which is key to determining the appropriate management step. The correct answer, choice A, is correct because it aligns with guidelines recommending evaluation for associated DCIS or invasive disease requiring surgical management. Choice B is incorrect because it represents undertreatment with topical therapy, which often arises from confusing malignant with benign dermatologic conditions. To effectively manage breast disease cases, students should stay updated on guidelines, understand risk stratification, and practice integrating clinical findings with management planning.
A 58-year-old woman is diagnosed with a 0.9-cm ductal carcinoma in situ (DCIS) detected on screening mammography as clustered microcalcifications. She has no palpable mass. Stereotactic core biopsy confirms DCIS, ER positive, with no invasion. Breast MRI shows no additional lesions. She prefers breast conservation. The surgeon explains that standard management is breast-conserving surgery (lumpectomy) with negative margins followed by whole-breast radiation to reduce local recurrence; sentinel lymph node biopsy is generally not required with lumpectomy for pure DCIS but may be considered with mastectomy.
Which treatment option is most aligned with current clinical guidelines for this condition?
Routine axillary lymph node dissection at time of lumpectomy
Lumpectomy with negative margins followed by whole-breast radiation therapy
Observation only because DCIS cannot progress to invasive cancer
Neoadjuvant chemotherapy to shrink DCIS before surgery
Radical mastectomy with pectoralis removal to prevent recurrence
Explanation
This question tests USMLE Step 2 CK skills in surgical oncology and breast disease management, focusing on evidence-based clinical decision-making. Understanding breast cancer management involves recognizing appropriate diagnostic and treatment strategies based on patient presentation and current guidelines. In this scenario, the patient's clinical findings and test results suggest small, non-invasive DCIS suitable for breast conservation, which is key to determining the appropriate management step. The correct answer, choice A, is correct because it aligns with guidelines recommending lumpectomy with negative margins followed by radiation to reduce recurrence. Choice D is incorrect because it represents unnecessary nodal surgery, which often arises from overgeneralizing invasive cancer protocols to DCIS. To effectively manage breast disease cases, students should stay updated on guidelines, understand risk stratification, and practice integrating clinical findings with management planning.
A 60-year-old woman with newly diagnosed breast cancer has a 2.2-cm invasive ductal carcinoma, ER/PR positive, HER2 negative. She is clinically node-negative. She is scheduled for lumpectomy and sentinel lymph node biopsy. She asks what happens if the sentinel nodes are negative. The surgeon explains that sentinel lymph node biopsy is the standard staging procedure for clinically node-negative disease and avoids morbidity of full axillary dissection; if sentinel nodes are negative, no further axillary surgery is indicated. If limited sentinel node positivity is found in select patients receiving breast-conserving therapy and radiation, axillary dissection may still be avoided.
Which of the following is most aligned with current clinical guidelines for this condition?
Avoid any nodal staging because tumor size is under 3 cm
Perform sentinel lymph node biopsy; if negative, omit further axillary surgery
Perform routine axillary lymph node dissection for all invasive cancers
Biopsy contralateral axillary nodes to exclude occult bilateral spread
Use PET/CT instead of surgical nodal staging to reduce complications
Explanation
This question tests USMLE Step 2 CK skills in surgical oncology and breast disease management, focusing on evidence-based clinical decision-making. Understanding breast cancer management involves recognizing appropriate diagnostic and treatment strategies based on patient presentation and current guidelines. In this scenario, the patient's clinical findings and test results suggest clinically node-negative invasive carcinoma requiring axillary staging, which is key to determining the appropriate management step. The correct answer, choice A, is correct because it aligns with guidelines recommending sentinel lymph node biopsy, omitting further surgery if negative to minimize morbidity. Choice B is incorrect because it represents overtreatment with routine dissection, which often arises from outdated practices predating sentinel node techniques. To effectively manage breast disease cases, students should stay updated on guidelines, understand risk stratification, and practice integrating clinical findings with management planning.
A 57-year-old woman presents with back pain and fatigue 6 years after treatment of ER-positive breast cancer with lumpectomy, radiation, and 5 years of endocrine therapy. She reports new mid-thoracic pain worse at night. Exam shows mild tenderness over the thoracic spine but no neurologic deficits. Labs reveal elevated alkaline phosphatase and normal calcium. She has no breast mass on exam. Given concern for metastatic recurrence, the clinician explains that evaluation typically includes imaging for bone metastases and staging studies; management of metastatic ER-positive disease often includes systemic endocrine therapy with targeted agents, with local therapy for symptom control.
Which of the following is the most appropriate next step in management for this patient?
Obtain imaging for suspected bone metastases, such as bone scan or PET/CT
Start empiric antibiotics for presumed vertebral osteomyelitis
Schedule prophylactic mastectomy to prevent metastatic progression
Reassure and treat as musculoskeletal strain without further workup
Repeat screening mammography only, as it detects most recurrences
Explanation
This question tests USMLE Step 2 CK skills in surgical oncology and breast disease management, focusing on evidence-based clinical decision-making. Understanding breast cancer management involves recognizing appropriate diagnostic and treatment strategies based on patient presentation and current guidelines. In this scenario, the patient's clinical findings and test results suggest possible bone metastases with elevated alkaline phosphatase years post-treatment, which is key to determining the appropriate management step. The correct answer, choice A, is correct because it aligns with guidelines recommending bone scan or PET/CT for symptomatic evaluation in suspected recurrence. Choice B is incorrect because it represents diagnostic omission, which often arises from attributing symptoms to benign causes without investigation. To effectively manage breast disease cases, students should stay updated on guidelines, understand risk stratification, and practice integrating clinical findings with management planning.